骨成長刺激装置の世界市場 - 市場考察、競合情勢、市場予測（2032年）

世界の骨成長刺激装置の市場規模は、2024年に13億3,703万米ドルであり、2032年までに20億2,113万米ドルに達すると予測され、2025年～2032年の予測期間にCAGRで5.34%の成長が見込まれます。骨関連疾患、スポーツ傷害、事故の発生率の上昇が、骨成長刺激装置の需要を世界的に促進しています。骨折、骨粗鬆症、外傷を経験する人が増える中、骨成長刺激装置は回復を促進し、特に高齢化した集団やスポーツ選手の転帰を改良するのに役立っています。さらに、市場の主要企業による製品開発の増加は、非侵襲的でより効果的な骨成長刺激装置の技術革新につながっています。これらの進歩は、より迅速で信頼性の高い骨治癒に対するニーズの高まりもあり、骨成長刺激装置市場全体を総体的に押し上げています。これらの要因により、2025年～2032年の予測期間に骨成長刺激装置市場が活性化する見込みです。

骨成長刺激装置の市場力学

世界保健機関（WHO）（2023）の最新のデータによると、世界で約5億2,800万人が変形性関節症、1,800万人が関節リウマチを患っています。もっとも多く侵されている関節は膝関節で3億6,500万人、次いで股関節、手関節となっています。どの疾患も骨の自然治癒力が損なわれることが多く、骨の再生と修復を促進する治療が必要となります。骨の治癒を刺激するために電界、超音波、磁界を使用する骨成長刺激装置は、これらの症状を管理する上で不可欠なツールになりつつあり、それによって世界中の骨成長刺激装置市場全体を押し上げています。

さらに、交通事故の増加も骨成長刺激装置の需要の増加につながる大きな要因です。世界保健機関（WHO）（2023）が提供した近年のデータによると、約2,000万人～5,000万人が非致死的な怪我を負い、その多くが交通事故による障害を負っています。道路交通事故（RTA）は外傷、特に骨折や重度の骨損傷の主因であり、骨成長刺激装置の市場を大幅に押し上げる可能性があります。これらのデバイスは、特に従来の治癒方法では不十分な複雑骨折やリスクの高い骨折の治癒過程を促進します。

さらに、世界保健機関（WHO）（2024）が提供した近年のデータによると、世界全体で1,500万人以上が脊髄損傷とともに生活しています。脊髄損傷はしばしば重度の骨折や椎骨損傷を引き起こし、骨の治癒や脊椎の安定性を損なう可能性があります。脊髄損傷患者は、脊椎を安定させ回復を促進するために、脊椎固定術などの手術を頻繁に必要とします。電気的、磁気的、超音波的刺激を使用する骨成長刺激装置は、このような症例で骨再生を促進し、癒合を成功させるための補助療法として使用されることが多くなっています。

さらに、世界中で製品の上市や承認が増加していることが、骨成長刺激装置の市場全体をさらに押し上げています。例えば2024年4月、Xstim, Inc.はXstim（TM）Spine Fusion StimulatorのFDA承認を取得しました。Xstimの脊椎固定デバイスは、脊椎固定術後の患者の骨治癒を促進する低エネルギーの信号を発する装着型の非侵襲的骨成長刺激装置です。

しかし、侵襲的な骨成長刺激装置は電極の外科的植込みが必要であり、感染、出血、麻酔に関する合併症などの手術に伴うリスクを引き起こすことや、製品リコールの増加が骨成長刺激装置市場の今後の成長を妨げる可能性があります。

北米が骨成長刺激装置市場全体を独占すると予測される

すべての地域の中で、北米が2024年に世界の骨成長刺激装置市場で最大のシェアを保持すると予測されています。この成長の主な促進要因としては、骨関連疾患の有病率の上昇やスポーツ傷害や事故の増加、政府の支援策、戦略的開発に積極的に取り組む主要市場企業のプレゼンスなどが挙げられます。これらの要因により、同地域における骨成長刺激装置の需要は大きく伸びると予測されます。

当レポートでは、世界の骨成長刺激装置市場について調査分析し、市場規模と予測、過去3年の製品/技術開発、市場の主要企業、利用可能な機会などの情報を提供しています。

目次

第1章 骨成長刺激装置市場レポートのイントロダクション

第2章 骨成長刺激装置市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 骨成長刺激装置市場の主な要因の分析

• 骨成長刺激装置市場の促進要因
• 骨成長刺激装置市場の抑制要因と課題
• 骨成長刺激装置市場の機会

第6章 骨成長刺激装置市場のポーターのファイブフォース分析

第7章 骨成長刺激装置市場の評価

• 製品別
  • 骨成長刺激デバイス
  • 骨形成タンパク質（BMP）
  • 多血小板血漿（PRP）
• 用途別
  • 脊椎固定術
  • 癒合遷延・癒合不全骨折
  • 口腔・顎顔面手術
  • その他
• エンドユーザー別
  • 病院
  • 在宅ケア
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 骨成長刺激装置市場の企業と製品のプロファイル

• Zimmer Biomet
• Orthofix Medical Inc.
• DJO, LLC
• Bioventus
• BTT Health GmbH
• Stimulate Health
• Kinex Medical Company, LLC.
• Fintek Bio-Electric Inc.
• Regen Lab SA
• Arthrex, Inc.
• Altis Biologics (Pty) Ltd.
• TERUMO BCT, INC.
• Medtronic
• DePuy Synthes (Johnson & Johnson)
• T-Biotechnology
• D.r PRP USA LLC.
• Ossatec ベネルクス BV
• ITO Co., Ltd.
• Theragen
• Xstim, Inc.

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Bone Growth Stimulators Market in Global (2022-2032)
• Table 3: Bone Growth Stimulators Market in Global by Product (2022-2032)
• Table 4: Bone Growth Stimulators Market in Global by Application (2022-2032)
• Table 5: Bone Growth Stimulators Market in Global by End-User (2022-2032)
• Table 6: Bone Growth Stimulators Market in Global by Geography (2022-2032)
• Table 7: Bone Growth Stimulators Market in North America (2022-2032)
• Table 8: Bone Growth Stimulators Market in the United States (2022-2032)
• Table 9: Bone Growth Stimulators Market in Canada (2022-2032)
• Table 10: Bone Growth Stimulators Market in Mexico (2022-2032)
• Table 11: Bone Growth Stimulators Market in Europe (2022-2032)
• Table 12: Bone Growth Stimulators Market in France (2022-2032)
• Table 13: Bone Growth Stimulators Market in Germany (2022-2032)
• Table 14: Bone Growth Stimulators Market in United Kingdom (2022-2032)
• Table 15: Bone Growth Stimulators Market in Italy (2022-2032)
• Table 16: Bone Growth Stimulators Market in Spain (2022-2032)
• Table 17: Bone Growth Stimulators Market in the Rest of Europe (2022-2032)
• Table 18: Bone Growth Stimulators Market in Asia-Pacific (2022-2032)
• Table 19: Bone Growth Stimulators Market in China (2022-2032)
• Table 20: Bone Growth Stimulators Market in Japan (2022-2032)
• Table 21: Bone Growth Stimulators Market in India (2022-2032)
• Table 22: Bone Growth Stimulators Market in Australia (2022-2032)
• Table 23: Bone Growth Stimulators Market in South Korea (2022-2032)
• Table 24: Bone Growth Stimulators Market in Rest of Asia-Pacific (2022-2032)
• Table 25: Bone Growth Stimulators Market in the Rest of the World (2022-2032)
• Table 26: Bone Growth Stimulators Market in the Middle East (2022-2032)
• Table 27: Bone Growth Stimulators Market in Africa (2022-2032)
• Table 28: Bone Growth Stimulators Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Bone Growth Stimulators Market in Global (2022-2032)
• Figure 3: Bone Growth Stimulators Market in Global by Product (2022-2032)
• Figure 4: Bone Growth Stimulators Market in Global by Application (2022-2032)
• Figure 5: Bone Growth Stimulators Market in Global by End-User (2022-2032)
• Figure 6: Bone Growth Stimulators Market in Global by Geography (2022-2032)
• Figure 7: Bone Growth Stimulators Market in North America (2022-2032)
• Figure 8: Bone Growth Stimulators Market in the United States (2022-2032)
• Figure 9: Bone Growth Stimulators Market in Canada (2022-2032)
• Figure 10: Bone Growth Stimulators Market in Mexico (2022-2032)
• Figure 11: Bone Growth Stimulators Market in Europe (2022-2032)
• Figure 12: Bone Growth Stimulators Market in France (2022-2032)
• Figure 13: Bone Growth Stimulators Market in Germany (2022-2032)
• Figure 14: Bone Growth Stimulators Market in United Kingdom (2022-2032)
• Figure 15: Bone Growth Stimulators Market in Italy (2022-2032)
• Figure 16: Bone Growth Stimulators Market in Spain (2022-2032)
• Figure 17: Bone Growth Stimulators Market in the Rest of Europe (2022-2032)
• Figure 18: Bone Growth Stimulators Market in Asia-Pacific (2022-2032)
• Figure 19: Bone Growth Stimulators Market in China (2022-2032)
• Figure 20: Bone Growth Stimulators Market in Japan (2022-2032)
• Figure 21: Bone Growth Stimulators Market in India (2022-2032)
• Figure 22: Bone Growth Stimulators Market in Australia (2022-2032)
• Figure 23: Bone Growth Stimulators Market in South Korea (2022-2032)
• Figure 24: Bone Growth Stimulators Market in Rest of Asia-Pacific (2022-2032)
• Figure 25: Bone Growth Stimulators Market in the Rest of the World (2022-2032)
• Figure 26: Bone Growth Stimulators Market in the Middle East (2022-2032)
• Figure 27: Bone Growth Stimulators Market in Africa (2022-2032)
• Figure 28: Bone Growth Stimulators Market in South America (2022-2032)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Market Opportunities
• Figure 32: PORTER'S Five Force Analysis

Bone Growth Stimulators Market by Product (Bone Growth Stimulation Devices [Non-Invasive Bone Growth Stimulators {Combined Magnetic Field (CMF) Devices, Capacitive Coupling (CC) Devices, Pulsed Electromagnetic Field (PEMF) Devices, and Ultrasonic Bone Growth Stimulators}, and Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), and Platelet-Rich Plasma (PRP)), Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), End-User (Hospitals, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising incidence of bone-related disorders, increase in sports injuries and accidents, and increase in product development activities by key market players across the globe.

The bone growth stimulator market was valued at USD 1,337.03 million in 2024, growing at a CAGR of 5.34% during the forecast period from 2025 to 2032, to reach USD 2,021.13 million by 2032. The rising incidence of bone-related conditions, sports injuries, and accidents is driving demand for bone growth stimulators globally. As more people experience fractures, osteoporosis, and trauma, bone growth stimulator helps accelerate recovery and improve outcomes, especially for aging populations and athletes. Additionally, increased product development by key market players has led to innovations in non-invasive and more effective bone growth stimulator technologies. These advancements, combined with the growing need for faster, reliable bone healing, are collectively boosting the overall market for bone growth stimulators. Collectively, these factors are expected to boost the market for bone growth stimulators during the forecast period from 2025 to 2032.

Bone Growth Stimulators Market Dynamics:

According to the latest data provided by the World Health Organization (WHO) (2023), approximately 528 million people globally were living with osteoarthritis and 18 million people were living with rheumatoid arthritis. The knee was the most commonly affected joint, with 365 million cases, followed by the hip and hand joints. In both conditions, the natural healing of bones is often impaired, necessitating interventions that promote bone regeneration and repair. Bone growth stimulators, which use electrical, ultrasound, or magnetic fields to stimulate bone healing, are becoming essential tools in managing these conditions thereby boosting the overall market of bone growth stimulators across the globe.

Moreover, the rise in road traffic accidents is another major factor leading to the rising demand for bone growth stimulators. According to the recent data provided by the World Health Organization (WHO) (2023), approximately 20 to 50 million people suffered non-fatal injuries, with many incurring a disability in road traffic injuries. Road traffic accidents (RTAs) are a major contributor to traumatic injuries, particularly fractures and severe bone damage, which can significantly boost the market for bone growth stimulators. These devices accelerate the healing process, especially in complex or high-risk fractures where traditional healing methods may be insufficient.

Additionally, as per the recent data provided by the World Health Organization (2024), globally, over 15 million people were living with spinal cord injury. Spinal cord injuries often result in severe fractures and vertebral damage, which can impair bone healing and spinal stability. Patients with spinal cord injuries frequently require surgeries, such as spinal fusions, to stabilize the spine and facilitate recovery. Bone growth stimulators, which use electrical, magnetic, or ultrasound stimulation, are increasingly used as an adjunct therapy to enhance bone regeneration and promote successful fusion in these cases.

Moreover, the increase in product launches and approval across the globe is further propelling the overall market of bone growth stimulators. For instance, in April 2024, Xstim, Inc., received FDA approval for Xstim(TM) Spine Fusion Stimulator. Xstim's spinal fusion device is a wearable non-invasive bone growth stimulation device that emits a low-energy signal that promotes bone healing in patients following spinal fusion surgery.

However, invasive bone growth stimulators require surgical implantation of electrodes, which introduces risks associated with surgery, such as infection, bleeding, and complications related to anesthesia and the increased number of product recalls may hinder the future market of bone growth stimulators market growth.

Bone Growth Stimulators Market Segment Analysis:

Bone Growth Stimulators Market by Product (Bone Growth Stimulation Devices [Non-Invasive Bone Growth Stimulators {Combined Magnetic Field (CMF) Devices, Capacitive Coupling (CC) Devices, Pulsed Electromagnetic Field (PEMF) Devices, and Ultrasonic Bone Growth Stimulators}, and Invasive Bone Growth Stimulators], Bone Morphogenetic Proteins (BMP), and Platelet-Rich Plasma (PRP)), Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), End-User (Hospitals, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the bone growth stimulators market, the Capacitive Coupling (CC) devices category is expected to hold the largest share in the year 2024. Capacitive coupling devices are significantly boosting the overall market of bone growth stimulators due to their non-invasive nature and proven effectiveness in enhancing bone healing. These devices work by delivering a low-level electrical signal through capacitive plates placed on the skin, creating an electric field that stimulates bone cells to accelerate the healing process. Unlike invasive procedures, capacitive coupling devices offer a safer and more comfortable option for patients recovering from fractures, spinal fusions, or non-union bones. Their ability to be used in home settings and their portability increase patient compliance and accessibility, making them a favored option in the orthopedic and trauma care markets. Additionally, capacitive coupling devices are particularly beneficial for patients who cannot undergo surgery or for whom conventional treatments have failed. As awareness of these benefits grows, alongside advancements in capacitive coupling technology, the demand for bone growth stimulators has seen a marked increase, further expanding the market. Moreover, the cost-effectiveness and ease of use of capacitive coupling devices make them an attractive option for healthcare providers, contributing to their growing adoption in both hospital and outpatient settings.

Several innovative CC-based products illustrate the impact of this technology on the market. For instance, the Xstim(TM) Spine Fusion Stimulator by Xstim, Inc., is a non-invasive device designed to promote bone growth following spinal fusion surgery. It features an intuitive interface and a built-in capacitive coupling mechanism to deliver consistent, effective therapy. Another example is Theragen's ActaStim(R) System, which offers a sleek, wearable solution combining CC-based electrical stimulation with real-time data collection for enhanced compliance and personalized care. These devices are gaining traction not only in the United States but also in global markets, driven by the increasing incidence of spinal disorders, orthopedic trauma, and demand for alternatives to repeat surgeries. As clinical evidence continues to support their efficacy and manufacturers integrate user-friendly features and digital connectivity, capacitive coupling devices are playing a pivotal role in the growth of the bone growth stimulator market.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global bone growth stimulators market during the forecast period.

North America is expected to dominate the overall bone growth stimulators market:

Among all regions, North America is expected to hold the largest share of the global bone growth stimulators market in 2024. Key drivers fueling this growth include the rising prevalence of bone-related disorders, an increase in sports-related injuries and accidents, supportive government initiatives, and the strong presence of key market players actively engaged in strategic developments. Collectively, these factors are anticipated to significantly boost the demand for bone growth stimulators across the region.

According to recent data from the Centers for Disease Control and Prevention (CDC, 2024), the age-adjusted prevalence of diagnosed arthritis among U.S. adults aged 18 and older was 18.9% in 2022. Women were more likely to be affected (21.5%) than men (16.1%). The prevalence of arthritis increases with age, rising from 3.6% among adults aged 18-34 to 53.9% in those aged 75 and older. As arthritis progresses, it often results in joint deterioration, bone erosion, and non-healing fracture conditions that require advanced interventions to stimulate bone regeneration. Bone growth stimulators, which utilize electrical or ultrasound stimulation, play a critical role in accelerating bone healing and alleviating pain. Their use in managing arthritis-related complications is therefore contributing to the expansion of the market in North America.

Furthermore, as per CDC data (2023), there were approximately 25.5 million emergency department visits in the U.S. due to unintentional injuries. The growing number of injuries increases the need for effective bone healing technologies. Bone growth stimulators offer improved recovery times and reduced complications, making them a valuable solution for a broad range of injury-related cases.

In addition, the presence of leading medical device manufacturers such as Arthrex Inc., Stryker Corporation, and Medtronic along with their strategic initiatives focused on product innovation and expansion further drives market growth in the region. These companies are actively developing advanced bone growth stimulators to address a variety of bone-related conditions, strengthening the market landscape and enhancing access to innovative solutions.

In summary, the combination of a high disease and injury burden, robust healthcare infrastructure, active government initiatives, and the strong presence of leading players positions North America as a dominant force in the global bone growth stimulators market during the forecast period.

Bone Growth Stimulators Market Key Players:

Some of the key market players operating in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC., Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd., TERUMO BCT, INC., Medtronic PLC, DePuy Synthes (Johnson & Johnson), T-Biotechnology, D.r PRP USA LLC., Ossatec Benelux BV, ITO Co., Ltd., Theragen, Xstim, Inc., and others.

Recent Developmental Activities in the Bone Growth Stimulators Market:

• In August 2022, Theragen, a biologics company, announced that it received the U.S. Patent for its ActaStim-S spine fusion bone growth stimulator system.
• In May 2022, Orthofix US LLC. received FDA approval for the AccelStim bone growth stimulator. The AccelStim bone growth stimulator delivers a high-frequency sound wave (ultrasound signal) to encourage bone growth and help heal broken bones (bone fractures).

Key takeaways from the bone growth stimulators market report study:

• Market size analysis for current bone growth stimulators size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the bone growth stimulators market.
• Various opportunities available for the other competitors in the bone growth stimulators market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current bone growth stimulators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for bone growth stimulators market growth in the coming future?

Target audience who can benefit from this bone growth stimulators market report study:

• Bone growth stimulator product providers
• Research organizations and consulting companies
• Bone growth stimulators-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in bone growth stimulators
• Various end-users who want to know more about the bone growth stimulators market and the latest technological developments in the bone growth stimulators market.

Frequently Asked Questions for the Bone Growth Stimulators Market:

1. What are bone growth stimulators?

• A bone stimulator is a device that generates an electric current used to promote bone growth. It uses ultrasonic or pulsed electromagnetic waves. Bone stimulators are either external or surgically implanted into the area of the affected bone.

2. What is the market for bone growth stimulators?

• The bone growth stimulator market was valued at USD 1,337.03 million in 2024, growing at a CAGR of 5.34% during the forecast period from 2025 to 2032, to reach USD 2,021.13 million by 2032.

3. What are the drivers for the bone growth stimulators market?

• The rising incidence of bone-related conditions, sports injuries, and accidents is driving demand for bone growth stimulators globally. As more people experience fractures, osteoporosis, and trauma, bone growth stimulator helps accelerate recovery and improve outcomes, especially for aging populations and athletes. Additionally, increased product development by key market players has led to innovations in non-invasive and more effective bone growth stimulator technologies. These advancements, combined with the growing need for faster, reliable bone healing, are collectively boosting the overall market for bone growth stimulators. Collectively, these factors are expected to boost the market for bone growth stimulators during the forecast period from 2025 to 2032.

4. Who are the key players operating in the bone growth stimulators market?

• Some of the key market players operating in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., DJO, LLC, Bioventus, BTT Health GmbH, Stimulate Health, Kinex Medical Company, LLC., Fintek Bio-Electric Inc., Regen Lab SA, Arthrex, Inc., Altis Biologics (Pty) Ltd., TERUMO BCT, INC., Medtronic PLC, DePuy Synthes (Johnson & Johnson), T-Biotechnology, D.r PRP USA LLC., Ossatec Benelux BV, ITO Co., Ltd., Theragen, Xstim, Inc., and others.

5. Which region has the highest share in the bone growth stimulators market?

• Among all the regions, North America is expected to hold the largest share of the global bone growth stimulators market in 2024. The key driving factors of the bone growth stimulators market are the increasing prevalence of bone-related disorders, an increase in sports-related injuries and accidents, increased government initiatives, and the presence of key players engaged in strategic activities in the region. Collectively, these factors are expected to boost the overall market of bone growth stimulators across the region.

Table of Contents

1. Bone Growth Stimulators Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Bone Growth Stimulators Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Bone Growth Stimulators Market Key Factors Analysis

• 5.1. Bone Growth Stimulators Market Drivers
  • 5.1.1. The rising incidence of bone-related disorders
  • 5.1.2. Increase in sports injuries and accidents
  • 5.1.3. Increase in product development activities by key market players across the globe.
• 5.2. Bone Growth Stimulators Market Restraints and Challenges
  • 5.2.1. Invasive bone growth stimulators require surgical implantation which introduces risks such as infection, bleeding, and complications
  • 5.2.2. The increased number of product recalls
• 5.3. Bone Growth Stimulators Market Opportunities
  • 5.3.1. Ongoing technological advancements such as enhanced electrical stimulation devices and ultrasound-based systems

6. Bone Growth Stimulators Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Bone Growth Stimulators Market Assessment

• 7.1. By Product
  • 7.1.1. Bone Growth Stimulation Devices
    • 7.1.1.1. Non-invasive Bone Growth Stimulators
    • 7.1.1.1.1. Combined Magnetic Field (CMF) Devices
    • 7.1.1.1.2. Capacitive Coupling (CC) Devices
    • 7.1.1.1.3. Pulsed Electromagnetic Field (PEMF) Devices
    • 7.1.1.1.4. Ultrasonic Bone Growth Stimulators
    • 7.1.1.2. Invasive Bone Growth Stimulators
  • 7.1.2. Bone Morphogenetic Proteins (BMP)
  • 7.1.3. Platelet-rich plasma (PRP)
• 7.2. By Application
  • 7.2.1. Spinal Fusion Surgeries
  • 7.2.2. Delayed Union & Nonunion Bone Fractures
  • 7.2.3. Oral & Maxillofacial Surgeries
  • 7.2.4. Others
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Homecare
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.1.2. Canada Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.1.3. Mexico Bone Growth Stimulators Market Size in USD million (2022-2032)
  • 7.4.2. Europe
    • 7.4.2.1. France Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.2. Germany Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.3. United Kingdom Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.4. Italy Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.5. Spain Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.2.6. Rest of Europe Bone Growth Stimulators Market Size in USD million (2022-2032)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.2. Japan Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.3. India Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.4. Australia Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.5. South Korea Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.3.6. Rest of Asia-Pacific Bone Growth Stimulators Market Size in USD million (2022-2032)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.4.2. Africa Bone Growth Stimulators Market Size in USD million (2022-2032)
    • 7.4.4.3. South America Bone Growth Stimulators Market Size in USD million (2022-2032)

8. Bone Growth Stimulators Market Company and Product Profiles

• 8.1. Zimmer Biomet
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Orthofix Medical Inc.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. DJO, LLC
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Bioventus
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. BTT Health GmbH
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Stimulate Health
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Kinex Medical Company, LLC.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Fintek Bio-Electric Inc.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Regen Lab SA
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Arthrex, Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Altis Biologics (Pty) Ltd.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. TERUMO BCT, INC.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Medtronic
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. DePuy Synthes (Johnson & Johnson)
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. T-Biotechnology
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. D.r PRP USA LLC.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Ossatec Benelux BV
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. ITO Co., Ltd.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Theragen
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Xstim, Inc.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us